Portfolio company
MiDx Ltd
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops lateral flow diagnostic tests for detecting microbial infections in patients with cystic fibrosis and other chronic respiratory conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rapid Myco
This company develops diagnostic tests for the rapid detection of mycobacterial infections in commercial livestock and humans.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
MicroWash
This company manufactures a nasal lavage device for medical professionals to collect respiratory specimens from patients for diagnostic testing.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
Astute Medical
This company develops in vitro diagnostic tests for hospitals and laboratories to identify sepsis, infectious diseases and other medical conditions.
Avelo
This company develops non-invasive breath sampling kits for the molecular diagnosis of respiratory infections like tuberculosis and pneumonia for clinicians and patients.
Highfield Diagnostics
This company develops laser-patterned paper substrates for multiplexed point-of-care diagnostic tests, serving healthcare providers, manufacturers, and individuals requiring self-monitoring for various diseases.
